Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies
Clinical trial NCT05221320 · TERMINATED
Trial details
- NCT number
- NCT05221320
- Sponsor
- BioMed Valley Discoveries, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-26
- Primary completion
- 2024-05-08
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.